Last: | $ |
---|---|
Change Percent: | -0.68% |
Open: | $86.56 |
Close: | $86.66 |
High: | $87.21 |
Low: | $84.8992 |
Volume: | 136,870 |
Last Trade Date Time: | 02/12/2020 04:43:29 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $86.56 | $86.66 | $87.21 | $84.8992 | 136,870 | 02-12-2020 |
$ | $88.87 | $87.25 | $90.01 | $83.53 | 286,734 | 02-11-2020 |
$ | $89.46 | $88.37 | $91.42 | $87.495 | 97,456 | 02-10-2020 |
$ | $92.70 | $88.98 | $93.00 | $86.16 | 222,435 | 02-07-2020 |
$ | $92.27 | $91.19 | $95.33 | $90.525 | 125,780 | 02-06-2020 |
$ | $91.13 | $92.01 | $93.1123 | $90.03 | 114,336 | 02-05-2020 |
$ | $95.46 | $90.72 | $96.01 | $90.225 | 152,381 | 02-04-2020 |
$ | $91.25 | $93.82 | $96.6641 | $91.00 | 141,150 | 02-03-2020 |
$ | $93.80 | $91.39 | $96.74 | $89.11 | 214,723 | 01-31-2020 |
$ | $99.00 | $93.55 | $99.27 | $89.68 | 370,142 | 01-30-2020 |
$ | $107.78 | $99.29 | $108.3585 | $98.03 | 284,720 | 01-29-2020 |
$ | $104.62 | $106.62 | $108.27 | $103.2976 | 245,273 | 01-28-2020 |
$ | $99.76 | $103.21 | $104.8933 | $97.02 | 334,877 | 01-27-2020 |
$ | $95.46 | $100.79 | $101.00 | $94.1575 | 328,050 | 01-24-2020 |
$ | $92.35 | $95.06 | $95.06 | $90.00 | 197,294 | 01-23-2020 |
$ | $89.54 | $91.81 | $96.7377 | $89.20 | 395,206 | 01-22-2020 |
$ | $84.99 | $87.75 | $88.86 | $83.01 | 207,483 | 01-21-2020 |
$ | $86.11 | $83.63 | $87.7579 | $80.27 | 140,668 | 01-20-2020 |
$ | $86.11 | $83.63 | $87.7579 | $80.27 | 140,659 | 01-17-2020 |
$ | $86.82 | $85.89 | $87.15 | $84.01 | 126,000 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
2024-06-28 07:15:04 ET Barclays analyst issues OVERWEIGHT recommendation for TXG on June 28, 2024 05:28AM ET. The previous analyst recommendation was Overweight. TXG was trading at $19.85 at issue of the analyst recommendation. The overall analyst consensus : HOLD. C...
New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies PR Newswire Researchers used Chromium Single Cell products and Xenium In Situ to profile how gene expression is spatially regulated during secondary palate formation PLEASAN...
2024-06-27 06:15:04 ET Wolfe Research analyst issues PEER PERFORM recommendation for TXG on June 27, 2024 04:49AM ET. TXG was trading at $19.5 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 3 - Buy, 5 -...